Tokyo Tape
Sign in
← Koa Shoji Holdings

Half-year report · Q2

9273.TEDINET S100V85J
Period2024-07-01 → 2024-12-31
Filed2025-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥12.3bn2024-07-01 → 2024-12-31Cons.Net sales
Revenue¥22.1bn2023-07-01 → 2024-06-30Cons.Net sales (5-year summary)
Revenue¥11.4bn2023-07-01 → 2023-12-31Cons.Net sales
Operating income¥3.1bn2024-07-01 → 2024-12-31Cons.Operating income
Operating income¥2.4bn2023-07-01 → 2023-12-31Cons.Operating income
Ordinary income¥3.1bn2024-07-01 → 2024-12-31Cons.Ordinary income
Ordinary income¥4.4bn2023-07-01 → 2024-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.4bn2023-07-01 → 2023-12-31Cons.Ordinary income
Profit before tax¥3.1bn2024-07-01 → 2024-12-31Cons.Income before income taxes
Profit before tax¥2.4bn2023-07-01 → 2023-12-31Cons.Income before income taxes
Net income (owners)¥2.0bn2024-07-01 → 2024-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.9bn2023-07-01 → 2024-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.6bn2023-07-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income¥2.0bn2024-07-01 → 2024-12-31Cons.Profit loss
Net income¥1.6bn2023-07-01 → 2023-12-31Cons.Profit loss
Total assets¥33.6bnat 2024-12-31Cons.Assets
Total assets¥32.0bnat 2024-06-30Cons.Assets
Total assets¥29.6bnat 2023-12-31Cons.Total assets (5-year summary)
Total liabilities¥7.0bnat 2024-12-31Cons.Liabilities
Total liabilities¥7.0bnat 2024-06-30Cons.Liabilities
Net assets / equity¥26.6bnat 2024-12-31Cons.Net assets
Net assets / equity¥25.1bnat 2024-06-30Cons.Net assets
Net assets / equity¥22.0bnat 2023-12-31Cons.Net assets (5-year summary)
Cash and deposits¥12.5bnat 2024-12-31Cons.Cash and deposits
Cash and deposits¥14.0bnat 2024-06-30Cons.Cash and deposits
Cash & equivalents¥9.8bnat 2024-12-31Cons.Cash and cash equivalents
Cash & equivalents¥13.2bnat 2024-06-30Cons.Cash and cash equivalents
Cash & equivalents¥10.3bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥10.0bnat 2023-06-30dCons.Cash and cash equivalents
Operating cash flow¥1.0bn2024-07-01 → 2024-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥3.8bn2023-07-01 → 2024-06-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.5bn2023-07-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥3.7bn2024-07-01 → 2024-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.5bn2023-07-01 → 2024-06-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥644m2023-07-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥738m2024-07-01 → 2024-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥795m2023-07-01 → 2024-06-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥639m2023-07-01 → 2023-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥48.662024-07-01 → 2024-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥74.142023-07-01 → 2024-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥39.462023-07-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio79.1%at 2024-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio78.3%at 2024-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio74.2%at 2023-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 28
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-07-01 → 2024-12-31−¥604m
Reconciling Itemsreconcilingrevenue intersegment2024-07-01 → 2024-12-31−¥604m
Reconciling Itemsreconcilingsegment profit2024-07-01 → 2024-12-31¥81m
jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segmentrevenue2024-07-01 → 2024-12-31¥8.0bn
jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segmentrevenue external2024-07-01 → 2024-12-31¥7.4bn
jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segmentrevenue intersegment2024-07-01 → 2024-12-31¥604m
jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segmentsegment profit2024-07-01 → 2024-12-31¥1.6bn
jpcrp040300-q2r_E34071-000Pharmaceutical Marketing Businessreportable segmentrevenue2024-07-01 → 2024-12-31¥4.9bn
jpcrp040300-q2r_E34071-000Pharmaceutical Marketing Businessreportable segmentrevenue external2024-07-01 → 2024-12-31¥4.9bn
jpcrp040300-q2r_E34071-000Pharmaceutical Marketing Businessreportable segmentsegment profit2024-07-01 → 2024-12-31¥1.4bn
—segment totalrevenue2024-07-01 → 2024-12-31¥12.9bn
—segment totalrevenue external2024-07-01 → 2024-12-31¥12.3bn
—segment totalrevenue intersegment2024-07-01 → 2024-12-31¥604m
—segment totalsegment profit2024-07-01 → 2024-12-31¥3.0bn
Reconciling Itemsreconcilingrevenue2023-07-01 → 2023-12-31−¥871m
Reconciling Itemsreconcilingrevenue intersegment2023-07-01 → 2023-12-31−¥871m
Reconciling Itemsreconcilingsegment profit2023-07-01 → 2023-12-31−¥38m
jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segmentrevenue2023-07-01 → 2023-12-31¥7.9bn
jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segmentrevenue external2023-07-01 → 2023-12-31¥7.0bn
jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segmentrevenue intersegment2023-07-01 → 2023-12-31¥871m
jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segmentsegment profit2023-07-01 → 2023-12-31¥1.4bn
jpcrp040300-q2r_E34071-000Pharmaceutical Marketing Businessreportable segmentrevenue2023-07-01 → 2023-12-31¥4.4bn
jpcrp040300-q2r_E34071-000Pharmaceutical Marketing Businessreportable segmentrevenue external2023-07-01 → 2023-12-31¥4.4bn
jpcrp040300-q2r_E34071-000Pharmaceutical Marketing Businessreportable segmentsegment profit2023-07-01 → 2023-12-31¥1.0bn
—segment totalrevenue2023-07-01 → 2023-12-31¥12.3bn
—segment totalrevenue external2023-07-01 → 2023-12-31¥11.4bn
—segment totalrevenue intersegment2023-07-01 → 2023-12-31¥871m
—segment totalsegment profit2023-07-01 → 2023-12-31¥2.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 494
ItemContextValueUnit
Short term loans payablePrior1YearInstant860000000JPY
Short term loans payableCurrentQuarterInstant860000000JPY
Current portion of long term loans payablePrior1YearInstant373904000JPY
Current portion of long term loans payableCurrentQuarterInstant373904000JPY
Income taxes payablePrior1YearInstant731912000JPY
Income taxes payableCurrentQuarterInstant1001434000JPY
Provision for bonusesPrior1YearInstant46676000JPY
Provision for bonusesCurrentQuarterInstant33277000JPY
Other clPrior1YearInstant759044000JPY
Other clCurrentQuarterInstant679714000JPY
Current liabilitiesPrior1YearInstant4976949000JPY
Current liabilitiesCurrentQuarterInstant5235240000JPY
Long term loans payablePrior1YearInstant1591384000JPY
Long term loans payableCurrentQuarterInstant1416432000JPY
Deferred tax liabilitiesPrior1YearInstant1129000JPY
Deferred tax liabilitiesCurrentQuarterInstant5883000JPY
Provision for directors retirement benefitsPrior1YearInstant151137000JPY
Provision for directors retirement benefitsCurrentQuarterInstant157000000JPY
Net defined benefit liabilityPrior1YearInstant152557000JPY
Net defined benefit liabilityCurrentQuarterInstant133572000JPY
Other nclPrior1YearInstant79183000JPY
Other nclCurrentQuarterInstant69789000JPY
Noncurrent liabilitiesPrior1YearInstant1975392000JPY
Noncurrent liabilitiesCurrentQuarterInstant1782679000JPY
LiabilitiesPrior1YearInstant6952341000JPY
LiabilitiesCurrentQuarterInstant7017920000JPY
Capital stockPrior1YearInstant1338752000JPY
Capital stockCurrentQuarterInstant1338752000JPY
Capital surplusPrior1YearInstant1022303000JPY
Capital surplusCurrentQuarterInstant1022303000JPY
Retained earningsPrior1YearInstant22643004000JPY
Retained earningsCurrentQuarterInstant24144790000JPY
Treasury stockPrior1YearInstant-407000JPY
Treasury stockCurrentQuarterInstant-407000JPY
Shareholders equityPrior1YearInstant25003652000JPY
Shareholders equityCurrentQuarterInstant26505438000JPY
Valuation difference on available for sale securitiesPrior1YearInstant41470000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant40896000JPY
Deferred gains or losses on hedgesPrior1YearInstant6552000JPY
Deferred gains or losses on hedgesCurrentQuarterInstant11673000JPY
Valuation and translation adjustmentsPrior1YearInstant48022000JPY
Valuation and translation adjustmentsCurrentQuarterInstant52569000JPY
Net assetsPrior1YearInstant25051674000JPY
Net assetsCurrentQuarterInstant26558008000JPY
Liabilities and net assetsPrior1YearInstant32004016000JPY
Liabilities and net assetsCurrentQuarterInstant33575928000JPY
Net salesPrior1YTDDuration11382942000JPY
Net salesCurrentYTDDuration12259451000JPY
Cost of salesPrior1YTDDuration7924332000JPY
Cost of salesCurrentYTDDuration8102120000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-06-30pass rounding
balance sheet identityconsolidated 2024-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-06-30pass
statement vs summary · net assetsconsolidated 2024-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2024-07-01/2024-12-31pass
statement vs summary · operating cash flowconsolidated 2023-07-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2024-07-01/2024-12-31pass
statement vs summary · revenueconsolidated 2023-07-01/2023-12-31pass
statement vs summary · revenueconsolidated 2024-07-01/2024-12-31pass
statement vs summary · total assetsconsolidated 2024-06-30pass
statement vs summary · total assetsconsolidated 2024-12-31pass